Literature DB >> 34248471

Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the Guidelines.

Michael P Lux1,2, Sonja Wasner1, Julia Meyer1, Lothar Häberle1, Carolin C Hack1, Sebastian Jud1, Alexander Hein1, Marius Wunderle1, Julius Emons1, Paul Gass1, Peter A Fasching1, Sainab Egloffstein3, Jessica Krebs4, Yesim Erim4, Matthias W Beckmann1,3, Christian R Loehberg1.   

Abstract

INTRODUCTION: Oncological second opinions are becoming increasingly important in the era of complex treatments and established certified cancer centers. Oncological guidelines with the highest levels of evidence are available, but these can only be effective to the extent that they are implemented. Therefore, we analyzed the effects of second opinions with regard to their agreement with first opinions and conformity with guidelines.
METHODS: In 164 patients with a diagnosis of breast cancer or gynecological malignancy who requested a second opinion, the first and second opinions, established at the interdisciplinary tumor conference, and conformity with the guidelines were evaluated.
RESULTS: The first opinion was not in agreement with the guidelines in 34.8% (15.2% diagnosis, 12.8% surgical therapy, 13.4% systemic therapy, and 5.5% radiotherapy), and the recommendations were optimized in the second opinion in 56.7% (28.7% diagnosis, 15.9% surgical therapy, 30.5% systemic therapy, and 8.5% radiotherapy).
CONCLUSIONS: Oncological second opinions showed significant effects and one-third of first opinions were not in conformity with the guidelines. In a significant proportion of cases, the existing treatment plan was changed or supplemented to allow modern and individualized treatment approaches.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Breast cancer; Certified cancer center; Guideline conformity; Gynecological oncology; Oncology center; Second opinion

Year:  2020        PMID: 34248471      PMCID: PMC8248777          DOI: 10.1159/000509127

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.268


  34 in total

1.  Changes in breast cancer therapy because of pathology second opinions.

Authors:  Valerie L Staradub; Kathleen A Messenger; Nanjiang Hao; Elizabeth L Wiley; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?

Authors:  Dominic Varga; Manfred Wischnewsky; Ziad Atassi; Regine Wolters; Verena Geyer; Kathrin Strunz; Rolf Kreienberg; Achim Woeckel
Journal:  Oncology       Date:  2010-04-23       Impact factor: 2.935

Review 3.  The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care.

Authors:  Simone Wesselmann; M W Beckmann; A Winter
Journal:  Arch Gynecol Obstet       Date:  2013-11-13       Impact factor: 2.344

4.  [Not Available].

Authors:  I Kopp; A Encke; W Lorenz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2002-03       Impact factor: 1.513

Review 5.  [Limited Data for Second Opinion Programs: a Systematic Review].

Authors:  J Ali; D Pieper
Journal:  Gesundheitswesen       Date:  2016-06-14

6.  Why do newly diagnosed breast cancer patients seek a second opinion? - Second opinion seeking and its association with the physician-patient relationship.

Authors:  Natalia Cecon; Marij A Hillen; Holger Pfaff; Antje Dresen; Sophie E Groß
Journal:  Patient Educ Couns       Date:  2018-12-13

7.  Why Do Cancer Patients Have Difficulties Evaluating the Need for a Second Opinion and What Is Needed to Lower the Barrier? A Qualitative Study.

Authors:  Karen S Peier-Ruser; Salome von Greyerz
Journal:  Oncol Res Treat       Date:  2018-11-21       Impact factor: 2.825

8.  Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.

Authors:  Monica Morrow; Reshma Jagsi; Amy K Alderman; Jennifer J Griggs; Sarah T Hawley; Ann S Hamilton; John J Graff; Steven J Katz
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

9.  Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.

Authors:  Achim Wöckel; Jasmin Festl; Tanja Stüber; Katharina Brust; Mathias Krockenberger; Peter U Heuschmann; Steffi Jírů-Hillmann; Ute-Susann Albert; Wilfried Budach; Markus Follmann; Wolfgang Janni; Ina Kopp; Rolf Kreienberg; Thorsten Kühn; Thomas Langer; Monika Nothacker; Anton Scharl; Ingrid Schreer; Hartmut Link; Jutta Engel; Tanja Fehm; Joachim Weis; Anja Welt; Anke Steckelberg; Petra Feyer; Klaus König; Andrea Hahne; Traudl Baumgartner; Hans H Kreipe; Wolfram Trudo Knoefel; Michael Denkinger; Sara Brucker; Diana Lüftner; Christian Kubisch; Christina Gerlach; Annette Lebeau; Friederike Siedentopf; Cordula Petersen; Hans Helge Bartsch; Rüdiger Schulz-Wendtland; Markus Hahn; Volker Hanf; Markus Müller-Schimpfle; Ulla Henscher; Renza Roncarati; Alexander Katalinic; Christoph Heitmann; Christoph Honegger; Kerstin Paradies; Vesna Bjelic-Radisic; Friedrich Degenhardt; Frederik Wenz; Oliver Rick; Dieter Hölzel; Matthias Zaiss; Gudrun Kemper; Volker Budach; Carsten Denkert; Bernd Gerber; Hans Tesch; Susanne Hirsmüller; Hans-Peter Sinn; Jürgen Dunst; Karsten Münstedt; Ulrich Bick; Eva Fallenberg; Reina Tholen; Roswita Hung; Freerk Baumann; Matthias W Beckmann; Jens Blohmer; Peter Fasching; Michael P Lux; Nadia Harbeck; Peyman Hadji; Hans Hauner; Sylvia Heywang-Köbrunner; Jens Huober; Jutta Hübner; Christian Jackisch; Sibylle Loibl; Hans-Jürgen Lück; Gunter von Minckwitz; Volker Möbus; Volkmar Müller; Ute Nöthlings; Marcus Schmidt; Rita Schmutzler; Andreas Schneeweiss; Florian Schütz; Elmar Stickeler; Christoph Thomssen; Michael Untch; Simone Wesselmann; Arno Bücker; Andreas Buck; Stephanie Stangl
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-11-26       Impact factor: 2.915

10.  Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.

Authors:  Peter Hillemanns; Klaus Friese; Christian Dannecker; Stefanie Klug; Ulrike Seifert; Thomas Iftner; Juliane Hädicke; Thomas Löning; Lars Horn; Dietmar Schmidt; Hans Ikenberg; Manfred Steiner; Ulrich Freitag; Uwe Siebert; Gaby Sroczynski; Willi Sauerbrei; Matthias W Beckmann; Marion Gebhardt; Michael Friedrich; Karsten Münstedt; Achim Schneider; Andreas Kaufmann; K Ulrich Petry; Axel P A Schäfer; Michael Pawlita; Joachim Weis; Anja Mehnert; Mathias Fehr; Christoph Grimm; Olaf Reich; Marc Arbyn; Jos Kleijnen; Simone Wesselmann; Monika Nothacker; Markus Follmann; Thomas Langer; Matthias Jentschke
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-02-18       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.